I?B[alpha] kinase inhibitor BAY 11-7082 promotes anti-tumor effect in RAS-driven cancers
I?B[alpha] kinase inhibitor BAY 11-7082 promotes anti-tumor effect in RAS-driven cancers
About this item
Full title
Author / Creator
Publisher
BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Oncogenic mutations in the RAS gene are associated with uncontrolled cell growth, a hallmark feature contributing to tumorigenesis. While diverse therapeutic strategies have been diligently applied to treat RAS-mutant cancers, successful targeting of the RAS gene remains a persistent challenge in the field of cancer therapy. In our study, we discov...
Alternative Titles
Full title
I?B[alpha] kinase inhibitor BAY 11-7082 promotes anti-tumor effect in RAS-driven cancers
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A800769237
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A800769237
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/s12967-024-05384-4
